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Munc13-4 Is Essential for Cytolytic Granules
Fusion and Is Mutated in a Form of Familial
Hemophagocytic Lymphohistiocytosis (FHL3)
cytotoxic granules at the immunological synapse.
HMunc13-4 is therefore essential for the priming step
of cytolytic granules secretion preceding vesicle
membrane fusion.
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1INSERM U429 cells are effector lymphocytes that share a common
Hoˆpital Necker-Enfants Malades cytotoxic pathway required for defense against virus-
75743 Paris infected or transformed cells (Russell and Ley, 2002).
France Cytotoxic cells kill their cognate target cells primarily
2 LMCP through the localized secretion of granules containing
CNRS UMR7590 perforin and granzymes (Griffiths and Isaaz, 1993;
Universite´s Paris 6 & Paris 7 Shresta et al., 1998). This process involves several steps,
Paris 75005 including recognition of the target cell by the cytotoxic
France cell, adhesion and the formation of a synapse between
3 Institut Curie-CNRS-UMR144 the two cells, rapid reorientation of the Golgi complex
75005 Paris and the microtubule organizing center (MTOC), and po-
France larization of the lytic granules of the CTLs toward the
4 Centre National de Ge´notypage target cell contact site (Kupfer and Singer, 1989). These
91057 Evry granules, which contain proteins capable of destroying
France the target cell, dock and fuse with the CTL plasma mem-
5 Unite´ d’Immunologie-He´matologie brane at the site of contact, leading to the release of
Hoˆpital Necker-Enfants Malades their contents (Peters et al., 1989; Stinchcombe et al.,
75015 Paris 2001b). The target cell is then rapidly killed (Rothstein
France et al., 1978). Molecular rearrangements at the cytotoxic,
6 Pediatric Hematology Unit immunological synapse and site of granule secretion
Schneider’s Children Medical Center have recently been described (Stinchcombe et al.,
49202 Petah Tikva 2001b; Vyas et al., 2002). In short, after cell-cell contact,
Israel talin and adhesion molecules such as LFA-1 concentrate
7 Unite´ d’Immuno-He´matologie at the contact site, forming a circular ring, to which the
Hoˆpital Robert Debre´ polarized MTOC anchors. This peripheral ring surrounds
75019 Paris a central supramolecular activation complex (cSMAC)
France containing signaling molecules such as Lck and PKC-.
The polarized granules insert into the cSMAC in a dis-
tinctive area before being secreted. Most of the compo-
Summary nents controlling secretion of the granule contents after
polarization have yet to be identified. The small GTPase
Secretion of cytolytic granules content at the immuno- Rab27a has been shown to be essential for the secretion
logical synapse is a highly regulated process essential of the contents of polarized granules. This Rab protein
for lymphocyte cytotoxicity. This process requires the therefore acts at a late stage of the exocytic pathway,
rapid transfer of perforin containing lytic granules to as demonstrated by studies of natural mutants of both
the target cell interface, followed by their docking and human and mice (Griscelli disease; Me´nasche´ et al.,
fusion with the plasma membrane. Defective cytotox- 2000) and ashen mice (Haddad et al., 2001; Stinchcombe
icity characterizes a genetically heterogeneous condi- et al., 2001a, respectively). The others components reg-
tion named familial hemophagocytic lymphohistio- ulating the docking, priming, and fusion steps are still
cytosis (FHL), which can be associated with perforin unknown. By analogy with better characterized secre-
deficiency. The locus of a perforin () FHL subtype tory cells, such as neurosecretory cells, granule mem-
(FHL3), observed in 10 patients, was mapped to 17q25. brane fusion events in lymphocytes should be mediated
This region contains hMunc13-4, a member of the by coordination of Rab-dependent membrane tethering,
Munc13 family of proteins involved in vesicle priming docking, and SNARE (soluble N-ethylmaleimide-sensi-
function. HMunc13-4 mutations were shown to cause tive fusion factor (NSF) attachment receptor-dependent
FHL3. HMunc13-4 deficiency results in defective cyto- membrane fusion (for recent review, see Jahn et al.,
lytic granule exocytosis, despite polarization of the 2003). In the SNARE model, t-SNAREs and v-SNAREs
secretory granules and docking with the plasma mem- (present on vesicle and target membranes, respectively)
brane. Expressed tagged hMunc13-4 localizes with assisted by proteins such as Munc18 homologs, are
thought to recognize each other specifically and to form
a core complex that brings the two membranes together,*Correspondence: sbasile@necker.fr
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ultimately leading to fusion (Jahn and Sudhof, 1999; polarization and membrane docking but is absolutely
Weber et al., 1998). In addition, proteins such as synap- required for the regulated secretion of cytotoxic gran-
totagmin 1, Munc13-1, and the complexins appear to ules at the priming stage of the exocytic pathway.
be crucial for Ca2-triggered exocytosis (Augustin et
al., 1999b; Rizo and Sudhof, 2002). Munc18-1 is though Results
to prevent formation of the core complex by binding to
the closed conformation of syntaxin-1 (Dulubova et al., Patients’ Characteristics
1999), whereas Munc13-1 and RIM should mediate the Ten patients from seven unrelated families (Figure 1A)
dissociation of Munc18-1 from syntaxin 1 enabling it to presented typical features of FHL, defined by early onset
enter into prefusion core complexes (Rizo and Sudhof, of overwhelming activation of T lymphocytes and mac-
2002; Sassa et al., 1999).Although this model is widely rophages and detection of activated (HLA DR) CD8 T
accepted, there is also considerable evidence for pro- lymphocytes in peripheral blood, associated with fever,
miscuity in the SNARE-SNARE interaction, and the rela- hepatosplenomegaly, pancytopenia, coagulation ab-
tionship between SNARE-complex formation and mem- normality, liver dysfunction, and features of hemopha-
brane fusion remains a matter of debate (Hu et al., 2003; gocytosis in the bone marrow or cerebrospinal fluid
Jahn et al., 2003; Lin and Scheller, 2000). (Table 1). All these patients presented defective anti
Impairment of the secretory cytotoxic pathway is ob- CD3-driven cytotoxic T cell activity (Figures 1B and 1C)
served in humans, in a group of rare autosomal recessive while intracellular perforin could be normally detected
immune disorders of lymphocyte homeostasis known (Table 1). FHL1 and FHL2 were excluded, based on the
as primary hemophagocytic syndrome (HS) (reviewed absence of disease segregation with the FHL1 (9q21-
in de Saint Basile and Fischer, 2001). Primary HS is 22) and FHL2 (10q21) loci and/or by perforin gene se-
characterized by multisystemic inflammation and organ quencing (data not shown). Patients’ hair shafts were
infiltration by polyclonal-activated CD8 T cells and analyzed by microscopy to exclude Che´diak-Higashi
macrophages. It is rapidly fatal in untreated patients. and Griscelli syndromes, two disorders with identical
One of these conditions, Griscelli syndrome type II, re- clinical and biological features, associated with partial
sults from mutations in the gene encoding the small albinism. The finding of an equal sex ratio among af-
GTPase Rab27a, an essential effector of lytic granule fected patients and the high frequency of consanguine-
exocytosis (Me´nasche´ et al., 2000). In a second condi- ous families (Figure 1A), were suggestive of an autoso-
tion, known as Che´diak-Higashi syndrome, mutations mal recessive inheritance pattern. We called this new
in the CHS gene lead to enlarged and functionally abnor- FHL group “FHL3” and searched for its molecular basis.
mal NK and CTL lytic granules (Baetz et al., 1995; Nagle
et al., 1996). Rab27a and CHS/LYST proteins are also Identification of the FHL3 Genetic Locus
involved in the intracellular transport of melanosomes, Genetic mapping was performed by studying the segre-
accounting for the partial albinism associated with these gation of polymorphic microsatellite markers in seven
two conditions. HS is the only feature of a third, geneti- families (six consanguineous), with ten patients (Figure
cally heterogeneous condition known as familial hemo- 1A). The genome-wide screen included 400 polymorphic
phagocytic lymphohistiocytosis (FHL) (Dufourcq-Lagel- markers. We carried out homozygosity mapping in six
ouse et al., 1999). The FHL1 locus has been mapped to families and bipoint LOD score analysis in all affected
chromosome 9q22, but the molecular basis of this form
families. We found that the D17S785 marker (telomeric
has yet to be determined (Ohadi et al., 1999). FHL2
region of the long arm of chromosome 17) was linked
phenotype is associated with inherited mutations in per-
with disease segregation in all families, with a maximumforin on chromosome 10q21 (Stepp et al., 1999). Thus,
LOD score of 8.07 (  0.00). We carried out furtherin humans, defective function of the granule secretory
analysis with additional markers located in this chromo-cytotoxic pathway results in the dysregulation of lym-
somal region. On the basis of recombination events andphocyte homeostasis, a characteristic feature of HS.
homozygous mapping in the consanguineous families,However, in a large proportion of FHL patients, no dis-
data from haplotype analysis defined D17S1351 andease segregation was found to be associated with these
D17S836 as the centromeric and telomeric flankingtwo loci.
markers for the critical genetic interval on 17q25.1, en-We report here that defective cytotoxic activity, inde-
compassing a 17 cM region (Figure 1D).pendent of perforin deficiency, functionally character-
izes a subset of FHL, which we have called FHL3. We
Identification of the hMunc13-4 Geneinvestigated the genetic basis of FHL3 by performing in
Several genes within the candidate region were selectedseveral families, a genome-wide search for susceptibil-
based on their expression and function in cytotoxic cellsity loci using polymorphic microsatellite markers. Strong
(SSI3, IRC1, LAK4P, HN1), or their potential role in vesi-linkage to chromosome 17q25 was found. DNA se-
cle trafficking or secretion (Sec4L, Sec14, Exo70, Synap-quences located in this region and encoding members
togyrin 2, GGA3, Septin 9, and Rab37). These genesof protein families potentially involved in secretion were
were sequenced. No mutations in these genes wereanalyzed for expression in hematopoietic tissues. A hu-
identified in FHL3 patients. We then carried out a sys-man sequence similar to rat Munc13-4 gene (Unc13h4)
tematic search of the nucleotide sequences releasedwas identified. We therefore investigated whether muta-
from the International Human Genome Sequencing Con-tions in human Munc13-4 gene (hMunc13-4) could
sortium. One of these sequences, (XM 113950), locatedcause FHL3. We describe six different mutations in
between D17S1807 and D17S785 (LOC 201294), washMunc13-4 in ten patients with FHL3 from seven fami-
lies. We show that Munc13-4 is not essential for granule derived from automated, computerized prediction anal-
Munc13-4 and Lytic Granules Fusion Defect in FHL3
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Figure 1. Identification of hMunc13-4 Mutations in FHL3 Patients
(A) Pedigree of the seven families included in the study: , deceased cases. Identification numbers indicate studied patients.
(B–C) Defective cytotoxic activity of T lymphocytes from FHL3 patients (B) less than 6 months of age: P83b (), P84 (), P3b (), P72 (),
P96 () and (C) over the age of 6 months: P45a (), P45b (), P83a (), P98 (). In each image, the gray areas correspond to the cytotoxic
activity of T cells from 15 age-matched controls. Cytotoxic activity was measured by assessing the lysis of Fas-deficient target cells in the
presence of anti-CD3 antibody. The effector-to-target cell ratio (x axis) reflects the ratio of CD8 T cells to L1210-3 target cells. Results are
expressed as a percentage of specific lysis (y axis), as measured by 51Cr release.
(D) Haplotype analysis of chromosome 17q25 polymorphic markers in the 10 FHL3 patients. Polymorphic markers were ordered according
to the NCBI Homo sapiens map (htp//www.ncbi.nlm.nih.gov/mapview). The phase in the patients was determined by analysis of parental
genotypes. Patients P45a and P45b are brothers from the only nonconsanguineous family and are shown in italics. The shaded area indicates
the candidate gene region. The position of the hMunc13-4 locus is indicated by a vertical bar with an asterisk.
(E) Schematic representation of the hMunc13-4 protein. The positions of the two C2 domains (C2A and C2B) and Munc13 homology domains
(MHD1 and MHD2) are indicated by amino acid number; the corresponding genomic organization of the hMunc13-4 gene, and the sites of
the mutations identified in the FHL3 patients are shown.
(F) Details of mutations in the hMunc13-4. In six of the seven families, the mutations were homozygous in patients (**), whereas in the remaining
family, heterozygous mutations were found (*). In four families of the same geographic origin, an identical in-frame deletion in the MHD1
domain was identified. The remaining mutations lead to frameshifts or stop codons (X).
ysis, and was characterized as encoding a protein simi- exons, each from 36 bp to 235 bp in size, predicted to
encode a protein of 1090 aa.lar to Rattus norvegicus Munc13-4 protein (online draft
release, January 2003, NCBI Human Genome annotation
program) (Figure 1D). Munc13 proteins constitute a fam- Mutations of hMunc13-4 in FHL3 Patients
As the Munc13-4 isoform identified in rat (Koch et al.,ily of proteins expressed in the brain, and Munc13-1
plays a central role in synaptic vesicle priming and exo- 2000) was found to be ubiquitously expressed, and
hMunc13-4 and FHL3 colocalize on chromosome 17q25,cytosis (Augustin et al., 1999b; Betz et al., 1998, 2001).
The structure of hMunc13-4 (Figure 1E) was deduced we studied hMunc13-4 as a possible candidate gene.
The coding sequence of hMunc13-4, including the 32by comparison of the cDNA sequence with the genomic
(NT:010641.12) sequence. HMunc13-4 consists of 32 exons and the adjacent intronic regions, was sequenced
Cell
464
Table 1. Patients’ Characteristics
Age at
diagnosis Hemophagocytosis CNSb Liver HLA DR ()d Perforin
Family Origin Patients (month) H/Sa Cytopenia (any site) involvment enzyme F/Hc among CD8(%) expression
1 Morocco P3a 3.5      / NEe 
P3b 2      / NE 
2 Pakistan P83a 12      / 79 
P83b 1.5      / 86 
3 Morocco P84 1.5      / 82 
4 Morocco P96 2      / 73 
5 Arabia P98 13      / NE 
6 France P72 4      / 33 
7 France P45a 3      / 80 
P45b 2      / 75 
a H/S  Hepatosplenomegaly
b CNS  Central nervous system
c F/H  Low fibrinogen level/hypertrygliceridemia
d Control value for HLA DR()/CD8   15
e NE  Not Evaluated
for all ten patients. Six different mutations were found tients’ cells, reaching control levels at similar effector/
target cell ratios (Figure 2). The cytotoxic activity of cells(Figures 1E–1F). The same homozygous 12 bp deletion
was observed in exon 20 in patients P3a, P3b, P84, and transfected with the insertless vector was similar to that
of nontransfected cells. Finally, the transfection ofP96, from three unrelated families of Moroccan origin.
Allele segregation analysis for the surrounding D17S1807 Rab27a-deficient cells with hMunc13-4 cDNA failed to
restore the cytotoxic activity of these cells (Figure 2).marker in these patients suggested the presence of a
founder effect (Figure 1D). This short exonic deletion Thus, the cytotoxic defect in FHL3 patients is directly
related to the described mutations in hMunc13-4.located within the Munc13 Homology domain 1 (MHD1)
of the protein (see below), preserved the open reading
frame, and was therefore predicted to encode a protein Expression and Structural Characteristics
of hMunc13-4lacking V608 to A611. Nucleotide changes in the canoni-
cal splice donor sequence were identified in patients We investigated the pattern of expression of hMunc13-4
in various human hematopoietic and nonhematopoieticfrom two families. In P72, a homozygous G to A transition
in the exon 15 splice donor resulted in the out-of-frame tissues by Northern blotting and RT-PCR analysis. A
major 4.5 kb transcript was readily detected in Northernsplicing of exon 14 to 16 resulting in a frameshift at
T464. A heterozygous G to T transition in the exon 9 blot analysis of poly A RNA from spleen, thymus, and
peripheral leukocytes whereas the band correspondingsplice donor was identified in P45a and P45b from family
7, leading to the out-of-frame splicing of exons 8 to 10, to this transcript was faint for RNA samples from the
small intestine, prostate, ovary, and colon (Figure 3A).and a frameshift at D252. The second allele in the pa-
tients from family 7 carried a heterozygous C to T nucleo- The expression of hMunc13-4 was found to be ubiqui-
tous in PCR analysis of a panel of cDNAs correspondingtide change in exon 10 that led to the formation of a
nonsense codon at R256. In family 2, a single homozy- to a wide range of hematopoietic and nonhematopoietic
tissues (Figures 3B–3C). For nonhematopoietic cells, thegous nucleotide deletion in exon 3 was detected leading
to a frameshift at residue 72, whereas in P98 a single lung and placenta gave a strong signal, whereas only a
weak signal was obtained for the brain, heart, skeletalnucleotide insertion in exon 20 caused a frameshift at
H586. In all these families, the parents available for test- muscle, and kidney. In contrast, a high level of hMunc13-4
expression was observed in all the hematopoietic cellsing were heterozygous for the mutation. The father of
P98 was not available for testing. The various genetic analyzed, including CD19 B lymphocytes, CD4 and CD8
T lymphocytes, and monocluclear cells, whether restingabnormalities identified in these FHL3 patients were not
found in the hMunc13-4 sequence of more than 100 or activated cells (Figure 3B) as well as the YT NK cell
line (data not shown). Thus, in contrast to other Munc13normal chromosomes from unrelated individuals, in-
cluding subjects of the same geographic origin. family members (Brose et al., 2000), this Munc13 isoform
displays a specific pattern of expression, being present
in large amounts in hematopoietic tissues but barelyHMunc13-4 Complements the Defect
of Cytotoxic Activity detectable in brain tissue.
Munc13-4 belongs to the Munc13-like family of pro-We carried out complementation experiments with cells
from P83b, P96, and P98, as a means of demonstrating teins, the members of which have two C2 domains sepa-
rated by long sequences containing two regions calledunequivocally that the hMunc13-4 deficiency was re-
sponsible for the defective cytotoxic activity associated Munc13-homology domains (MHD1 and MHD2) (Koch
et al., 2000) (Figure 4A). According to Nalefski and Falkewith the FHL3 phenotype. We introduced hMunc13-4
cDNA into the mammalian expression vector pIres- (1996), the two C2 domains of Munc13-4 exhibit different
topologies (mixed topology), depending on the circularEGFP. Transfection with the cDNA encoding wild-type
hMunc13-4 fully restored cytotoxic activity in the pa- permutation of the  strands, leaving the N and C termini
Munc13-4 and Lytic Granules Fusion Defect in FHL3
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Figure 2. Complementation of the T cell Cy-
totoxic Activity of FHL3 Patients with Wild-
Type (wt) hMunc13-4
T lymphocyte-mediated cytotoxic activities
of cells from three FHL3 patients (P83b, P96,
and P98), control cells and Rab27a-deficient
cells were measured as described in Figure
1B at a effector-to-target cell ratio of 10:1
before or 18 hr after transfection with wt-
hMunc13-4-pIRES2-EGFP vector or insert-
less pIRES2-EGFP vector (lower image).
Transfection efficiency was determined for
each construct by FACScan analysis of EGFP
production (upper image). The results shown
are representative of two independent exper-
iments with similar results, while error bars
show duplicates standard deviation.
either at the top or at the bottom of the C2  sandwich Ca4 asparagine (loop 2) (Figure 4B). These observations
suggest that both C2 domains are likely to bind two(for a review, see Nalefski and Falke, 1996; Rizo and
Sudhof, 1998). The first C2 domain (C2A) has a type I Ca2 ions, at sites 1 and 2, but that the presence of a
large insertion in loop 3 of C2A (27 aa) could affecttopology, similar to that encountered in cPLA2 and
PLC1, and the second one (C2B) has a type II topology, the Ca2 binding ability of this domain (Figure 4C). By
analogy with the cPLA2 helix inserted in loop 1 (Perisicsimilar to that observed in synaptotagmin 1 (Syt1) C2A
and C2B domains and in rabphilin (Figures 4B and 4C). et al., 1998), it is possible that this helix-containing inser-
tion in Munc13-4 (as in BAP3 and Munc13-1) insteadLike the rabphilin and Syt1 C2A domains, Munc13-4
C2 domains contain the five aspartic acids that form the makes a significant contribution to binding to mem-
branes or proteins. Another large insertion (23 aa) isCa1 and Ca2 calcium binding sites, located at the top
of the  sandwich formed by three loops (labeled 1 to located in the 3-4 loop of the C2A domain of
hMunc13-4, at the opposite side of the putative calcium3). They however lack the critical Ca3 serine (loop 3) and
Figure 3. Tissue Distribution of hMunc13-4 mRNA
(A) Northern blot analysis. A membrane with polyadenylated-enriched RNA from the human tissues indicated was successively hybridized
with a hMunc13-4 and a -actin probe.
(B–C) RT-PCR analysis, using commercial panels of cDNA from (B) hematopoietic and (C) nonhematopoietic tissues. G3PDH-specific primers
were used as a control.
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Figure 4. Domain Structure of hMunc13-4 and Comparison with Other C2-Domain Proteins
(A) Alignment of Munc13-4 proteins with human BAP3 (BAI-associated protein 3) and the hypothetical C. elegans protein F54G2.1. These
proteins have similar structures, with two C2 domains (shaded gray) flanking a central region containing two Munc13 homology regions (MHD1
and MHD2), as described by Koch et al. (2000) (dotted boxes). Protein names and amino acid numbers are indicated on the left side. Identical
residues are shown in white on a black background; similar residues are boxed. Secondary structure predictions, according to the PSI-PRED
program (Jones, 1999) are shown below the sequences, with black bars and gray arrows representing helices and strands, respectively. A
segment of the putative F54G2.1 protein from C. elegans (aa 971–1028) indicated by the symbol #, has not been reported as it likely corresponds
to an incorrectly predicted CDS. Hs  Homo sapiens, Rn  Rattus norvegicus, Ce  Caenorhabditis elegans. GenBank identifier (gi) numbers
are 27500274 (Hs Munc13-4), 20301982 (Rn Munc13-4), 15451914 (Hs BAP3), and 17568145 (Ce F54G2.1). Hs Munc13-4 is 87%, 34%, and
25% identical to Rn Munc13-4, Hs BAP3, and Ce F54G2.1, respectively.
(B) Alignment of hMunc13-4 C2 domains with several C2 domains with resolved three-dimensional structures (upper lines), and with the C2
domains of human BAP3 and rat Munc13-1. Positions for which at least seven of the 11 amino acids are identical or similar are shown in
white on a black background and shaded gray (white letters for hydrophobic amino acids, or amino acids that can substitute for them, black
letters for the others), respectively. Bars above the alignment indicate the locations of  strands (mean positions).  strands are labeled
according to type II topology, as found in synaptotagmin I C2 domains. The positions of amino acids with side chains coordinating Ca2 ions
in the various domains are also indicated, with arrows above the alignment, containing the name of the amino acid responsible for coordination
Munc13-4 and Lytic Granules Fusion Defect in FHL3
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binding site. This loop may be involved in the Ca2-
independent interaction of this domain with other part-
ners, as proposed for rabphilin, synaptotagmin C2B,
and synaptotagmin 3 C2B (Fernandez et al., 2001; Sutton
et al., 1999; Ubach et al., 1999).
In addition, we found that the MHD-containing region,
which separates both C2 domains, was composed al-
most exclusively of 	 helices, several of which were of
particular length, including clear heptad repeats typical
of coiled-coil-forming structures (Figure 4A). These
structures could be involved in oligomeric interactions.
Abolition of Cytotoxic Granule Exocytosis
by hMunc13-4 Mutations
We investigated the role of hMunc13-4 in the lympho-
cyte secretory process. Cytotoxic granules are regu-
lated secretory storage organelles that release their con-
tent upon TCR activation. Conversely, the release of
cytokines, such as 
-interferon (
-IFN), is dependent on
the constitutive secretory pathway (Fortier et al., 1989).
We investigated the granule exocytic pathway by mea-
suring the release of granzyme A by CD3-TcR-triggered
Figure 5. Secretion of Granule Contents, but not of 
IFN, Impairedlymphocytes, by means of a BLT-esterase assay. Gran-
in hMunc13-4-Deficient Cytotoxic T Cellszyme was undetectable in the supernatants of activated
(A) Percentage of total granzyme A secreted from CTLs of FHL3cells from FHL3 patients, after TcR crosslinking (Figure
patients and controls (Co, n  20) in response to crosslinking with5A). Under the same conditions, 65% of the contents
an anti-CD3 antibody. Cell supernatants were assayed by ELISA for
of control granule cells were released. For two patients, serine esterase. Data are expressed as the mean percentage  SD
we also analyzed the secretion of 
-IFN into the super- specific release (test/total release) for triplicate samples.
(B) Supernatants from two FHL3 patient samples (same experimentnatant. No difference in 
-IFN release was observed
as in A) were analyzed by ELISA for 
-IFN secretion.between FHL3 and control cells (Figure 5B). Thus,
hMunc13-4 plays a determinant role in the regulated
secretion of granules containing preformed secretory granules to the site of contact with the target cell mem-
products, but not in the secretion of vesicles associated brane. Similar results were obtained with Rab27a-defi-
with the constitutive secretory pathway used by lympho- cient CTL-target cell conjugates. This suggested that
cytes for cytokines secretion. hMunc13-4 was involved in the last steps of the secre-
tory process, i.e., vesicle docking, priming, or mem-
brane fusion.HMunc13-4 Is Not Required for Lytic Granule
Polarization and Docking at the To improve the resolution of polarized granule local-
ization with respect to the site of secretion, the sameImmunological Synapse
We tried to identify the step of cytotoxic granule release cell conjugates were studied by electron microscopy
(EM) (Figures 6C–6G). At the immunological synapse,in which hMunc13-4 functions, by assessing the ability
of lytic granules to polarize, toward the CTL-target cell the Golgi complex was found to be polarized close to
the site of membrane contact both in control and incontact in hMunc13-4-deficient cells. CTL-target cell
conjugates were induced under the same anti-CD3 trig- hMunc13-4-deficient CTLs. In hMunc13-4-deficient cell
conjugates (Figure 6F), as in control conjugates (Figuregering conditions used for cytotoxicity analysis. A CD8
antibody was used to identify effector cells within the 6C), granules were found closely associated with the
plasma membrane at the immunological synapse. How-CTL-target cell conjugate and an antibody specific for
perforin was used to detect lytic granules. Conjugate ever, the exocytic fusion of lytic granules (Figure 6D)
and the release of granule membranous contents intoformation was not affected by the Munc13-4 defect (Fig-
ures 6A–6B). In hMun13-4-deficient CTL, the lytic gran- the cellular cleft were observed only in control conju-
gates (Figure 6E). By analyzing a similar number ofules polarized toward the point of contact with the target
cell, as frequently (90% of cells) as granules from control Rab27a-deficient CTL-target cell conjugates, we de-
tected no lytic granule docked at the plasma membrane,CTL-target cell conjugates. Thus, hMunc13-4 is not re-
quired for the microtubule-mediated movement of lytic although some granules were observed close to the
and the sites (1 to 4) in which they are involved (after Rizo and Sudhof, 1998). N-terminal 1 strands aligned in italics with C-terminal ones.
The alignment and boundaries of the C2 domains were refined using hydrophobic cluster analysis (Callebaut et al., 1997).
(C) Ribbon representation of three-dimensional models of the two hMunc13-4 C2 domains. These models were constructed on the basis of
the alignment shown in (B), using Modeller 4 (Sali et al., 1995).  strands are labeled according to C2 type II topology, as adopted by the
second C2 domain (C2B) of hMunc13-4. The positions of large insertions within the first C2 domain (C2A), which were not modeled, are
indicated with black and gray arrows (loop between strands 3 and 4 and loop 3 between strands 6 and 7, respectively). A large helix is
predicted to be included in loop 3.
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Figure 6. Role of hMunc13-4 in Cytotoxic Granule Polarization and Docking at the Immunological Synapse
(A) HMunc13-4 is dispensable for cytotoxic granules polarization. Immunofluorescence study of CTL/L1210 target cell conjugates showing
that lytic granules from hMunc13-4-deficient CTLs (P83b) polarize normally toward target cells. Normal polarization is also observed in Rab27a-
deficient CTLs. The granules were stained with antibodies against perforin (green), the T cells were stained with antibodies against the CD8
membrane protein (red) and the nuclei were stained with DAPI (blue), in control T cells, hMunc13-4-deficient T cells (P83b) and Rab27a-
deficient T cell conjugates. The scale bar represents 5 m.
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immunological synapse (Figure 6G), confirming previous families. All the mutations are predicted to result in major
changes in the hMunc13-4 protein. All but one are pre-observations in the ashen Rab27a-deficient mouse
model (Stinchcombe et al., 2001a). Therefore, unlike dicted to cause C-terminal truncations of various
lengths (e.g., splice site, nonsense, frameshift). One mu-Rab27a, hMunc13-4 is dispensable for vesicle docking
at the plasma membrane. tation causes an in-frame deletion within a highly con-
served domain (MHD1), potentially affecting the overall
stability of the protein or identifying a critical functionalTagged-hMunc13-4 Polarizes
part of this Munc13-4 domain. A founder effect waswith Cytotoxic Granules
suggested for this mutation, which originated from aExpression of full-length hMunc13-4 protein tagged with
Moroccan family, although additional genetic evidencesred fluorescent protein (RFP) was used to determine its
would be required for its demonstration. The implicationsubcellular localization, in order to more directly analyze
of hMunc13-4 in FHL3 was confirmed by complemen-its site of action. When previously performed with the
tation of the cytotoxic activity defect in CTLs fromvarious rat Munc13-1,-2, and -3 isoforms (Betz et al.,
three patients upon transfection with the wild-type1998), a cytosolic distribution of these proteins was
hMunc13-4 cDNA.shown. Munc13-1,-2, and -3 translocate to the cyto-
The FHL3 phenotype was homogeneous and indistin-plasmic membrane upon phorbol-ester stimulation, via
guishable from that of patients with FHL2 (Stepp et al.,their C1 domain. The distribution of hMunc13-4, which
1999). Cytotoxic activity is deficient in both conditions,is devoid of a C1 domain, differs. In transfected control
due to defective lytic granule exocytosis and perforinCTLs, a fuzzy and patchy staining in the cytoplasmic
function, respectively, in these two conditions. This fur-area where the cytotoxic granules are regrouped was
ther demonstrates the crucial role of this cytotoxic path-observed (Figures 6H–6I). HMunc13-4 protein partially
way in the regulation of lymphocyte homeostasis in hu-colocalized with perforin (Figure 6J), suggesting that
mans (de Saint Basile and Fischer, 2001).only a fraction of the vesicles was associated with this
transiently expressed hMunc13-4. In contrast, the local-
ization of the Golgi apparatus was largely distinct (Figure HMunc13-4 Identification, Structure,
6K). In CTL-target cell conjugates, tagged-hMunc13-4 and Tissue Distribution
fully polarized at the site of the cell-cell contact, exten- The human sequence identified as Munc13-4 has a do-
sively colocalizing with the cytotoxic granules (Figures main structure similar to that of human BAP3, rat
6L–6M). Similar labeling patterns were observed in more Munc13-4, and a segment of the putative F54G2.1 pro-
than 80% of the cells. In contrast, expression of RFP tein from C. elegans. As this sequence is 87% identical
alone resulted in a diffuse cytoplasmic labeling as ex- to rat Munc13-4, and only 34% identical to human BAP3,
pected for a soluble protein (data not shown). These human Munc13-4 appears to be the true ortholog of rat
findings strongly support the view that hMunc13-4 func- Munc13-4. A molecular mass of 123 kDa is predicted
tions at the site at which cytotoxic granules dock at the from the newly identified human sequence, and this size
plasma membrane and undergo granule-cytoplasmic is similar to that of the 115 kDa Munc13-4 protein in rat
membrane fusion. tissue (Koch et al., 2000). Thus, the characterized human
open reading frame sequence probably corresponds to
entire hMunc13-4. The sequence identified in rat wasDiscussion
recognized as a member of the Munc family on the
basis of the typical domain architecture of the C-terminalHMunc13-4 Gene Mutations Cause FHL3 Disease
This study establishes hMunc13-4 as the gene responsi- region of Munc13/Unc13 family members. Previous
studies have shown that although members of this pro-ble for FHL3. Genetic studies in seven unrelated families
fulfilling the diagnostic criteria for FHL demonstrated tein family display divergent N termini, their C-terminal
regions are very similar, containing a diacylglycerol/strong linkage between disease segregation and a ge-
netic region on chromosome 17q25. Systematic survey phorbol ester binding C1 domain upstream from two
C2-domains that span two Munc13 homology regions.of the nucleotide sequences identified in this region
revealed the presence of a human ortholog of the rat This observation suggested that Munc13-like proteins
are built from two functional modules that have evolvedgene encoding Munc13-4. Six different changes in this
gene were identified in ten patients from these seven differently (Betz et al., 2001; Brose et al., 2000). The
(B) Corresponding Nomarski panels.
(C–G) HMunc13-4 is dispensable for cytotoxic granules docking. EM analysis of ultrathin sections of CTL/target cell conjugates. Control (C,
D and E), hMunc13-4-deficient (F), and Rab27a-deficient (G) CTLs (left) conjugated with L1210 target cells (right). In all cell types, the Golgi
apparatus and lytic granules polarize toward the immunological synapse. In control and hMunc13-4-deficient (P83b) CTL conjugates, granules
can be seen in close apposition to the plasma membrane at the contact sites (indicated by arrows in C and F). In Rab27a-deficient CTL
conjugates, lytic granules close to, but not associated with the plasma membrane are observed (G). Exocytic fusion of lytic granules from
control CTL are indicated by arrows in (D). In (E, arrow), note the presence of released membrane sheets and vesicles in the membrane cleft.
m, mitochondria; N, nucleus; GA, Golgi apparatus; LG, lytic granule. The scale bar represents 200 nm.
(H–M) Expression and localization of RFP-tagged hMunc13-4 in isolated- and target-conjugated-control CTL. RFP-tagged hMunc13-4 ex-
pressed in isolated CTLs (red in H–K) partially overlaps with the region containing perforin labeled granules (green in I–J), while differs from
Golgi apparatus (green in K). In CTL-target cell conjugate (L–M), RFP-tagged hMunc13-4 polarizes and extensively colocalizes with perforin
labeled cytotoxic granules (green in L) at the immunological synapse; corresponding Nomarski panel in (M). Nuclei were stained with DAPI
(blue). The scale bar represents 5 m.
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N-terminal region of Munc13-1, like that of its C. elegans scopical study confirmed that hMunc13-4-deficient lym-
phocytes make normal contacts with target cells, stableortholog, Unc-13, binds RIM1, a Rab3 effector with a
putative role in vesicle tethering (Betz et al., 2001). This conjugates, and reorganize the MTOC. It also demon-
strated that the polarization of MTOC/Golgi stacks andinteraction may direct the targeting of Munc13-1 itself to
the presynaptic active zones. The conserved C-terminal lytic granules occurs independently of hMunc13-4 func-
tion. Although granule exocytosis is impaired inregion, which contains interaction sites for several
Munc13/Unc13 effectors, such as syntaxin and DOC2	, hMunc13-4-deficient CTLs, several lytic granules were
seen closely associated with the plasma membrane atis necessary and sufficient for optimal secretory vesicle
priming in chromaffin cells (Ashery et al., 2000; Betz et the immunological synapse, in contrast to observations
made in Rab27a-deficient CTLs. A role for hMunc13-4al., 1997; Brose et al., 2000; Orita et al., 1997). This
priming function of Munc13-1 is thought to involve in a late step of the exocytic pathway, downstream from
Rab27a and between lytic granule docking and mem-switching of the “closed” conformation of syntaxin
(complexed with Munc18) to an open state, allowing brane fusion, therefore seems highly likely. This hypoth-
esis is also strongly supported by the observation thatsyntaxin to take part in the formation of SNARE com-
plexes (Richmond et al., 2001; Sassa et al., 1999). tagged-hMunc13-4 localized in the cytoplasmic area
where the cytotoxic granules are regrouped, and fullyMunc13-1 may therefore act as a physical bifunctional
linker between vesicle docking and priming. polarized at the immunological synapse, at the contact
site between granules and plasma membrane. Addi-No region equivalent to the N-terminal module of
Munc13-like proteins is found in hMunc13-4. However, tional studies will be required to better define the physi-
cal link between cytotoxic granules, Munc13-4, and po-the domain architecture of this protein (like that of BAP3)
is similar to that of the C-terminal region of Munc13-like tential additional binding partners, involved in the fusion
machinery. In most membrane fusion reactions, activeproteins, but without the C1 domain. Both C2 domains
of hMunc13-4 carry two putative Ca2 binding sites that Rabs on the donor membrane orchestrate the recruit-
ment of effectors on the acceptor membrane (for review,may, as in other C2 domains, mediate Ca2-dependent
phospholipid binding. The presence of a large 	-helix see Zerial and McBride, 2001). Rab proteins are thus
involved in the induction of membrane tethering. Afterinserted within loop-3 of the C2A domain of hMunc13-4
suggests that this domain may mediate membrane or membrane attachment, fusion is initiated by the con-
certed action of SNAREs and SM proteins (Sec1/protein interaction independently of Ca2 binding, as
previously described for several proteins in which the Munc18-like proteins). The SNARE membrane proteins
present on both fusion partners engage in trans-com-C2 domain has lost the ability to bind Ca2 (reviewed
in Nalefski and Falke, 1996). plexes that bridge the fusing membranes, a reaction
controlled by SM proteins (for recent reviews, see JahnThe presence of large helices harboring heptad re-
peats typical of coiled-coils between the hMunc13-4 C2 et al., 2003; Rizo and Sudhof, 2002). Our data strongly
suggest that in CTL, hMunc13-4 plays a role in priming.domains has not been reported before. This predicted
coiled-coil-forming structure may be involved in the in- Priming should occur between the Rab cycle (probably
involving Rab27a) and the SNARE cycle, making it possi-teraction of hMunc13-4 with its partners.
The Munc13-1, 2, and 3 and BAP3 proteins are exclu- ble for tethered vesicles to mature to a fusion-competent
state before membrane fusion occurs. It is unclearsively (Munc13-1, bMunc13-2, Munc13-3, BAP3) or prin-
cipally (ubMunc13-2) expressed in brain tissue (Augustin whether hMunc13-4 uses similar molecular pathways
at the immunological synapse to those described foret al., 1999a; Brose et al., 1995; Shiratsuchi et al., 1998).
In contrast, hMunc13-4 RNA was barely detectable in Munc13-1 at the neurological synapse, which convert
syntaxin 1 to an open conformation. In any case,the brain and present in large amounts in several tissues,
such as hematopoietic tissues, and lungs (this study hMunc13-4 is absolutely required for vesicle-plasma
membrane fusion.and Koch et al., 2000). Based on its structural similarity
to the C-terminal module of Munc13 proteins, and its
tissue specificity, hMunc13-4 is probably involved in late The Crucial Role of Munc13-4 Appears to Be
steps of the vesicular secretory pathway in nonneu- Restricted to the Cytotoxicity of Lymphocytes
ronal cells. Given the widespread expression of hMunc13-4, it is
surprising that FHL3 patients display a phenotype indis-
tinguishable from that of patients with perforin defi-Role of hMunc13-4 in CTL Function
HMunc13-4 mutations in FHL3 patients impair the re- ciency (Stepp et al., 1999). In particular, FHL3 patients
display no respiratory tract impairment, despite the largelease of lytic enzymes, but not of 
-IFN from TCR-acti-
vated lymphocytes. Thus, hMunc13-4 is an essential amounts of Munc13-4 detected in the goblet cells of rat
lung epithelium (Koch et al., 2000). This contrasts witheffector of the cytolytic secretory pathway, which makes
use of lytic enzymes stored in preformed granules. In the broader consequences of Rab27a deficiency, which
not only impairs this cytotoxic secretory pathway, butcontrast, TCR-induced exocytosis of the vesicles asso-
ciated with the constitutive secretory pathway is inde- also impairs melanosome transport in melanocytes
(Me´nasche´ et al., 2000). Thus, redundant mechanismspendent of hMunc13-4. Reorganization of membrane
receptors and signaling molecules necessary for the may take place in other cell types carrying out secretory
functions with similar characteristics. Alternatively, theformation of a functional immunological synapse is re-
quired for both granule secretion and 
-IFN secretion, functional characteristics of the hMunc13-4-dependent
secretory pathway may be restricted to cytotoxic lym-ruling out a crucial role for hMunc13-4 in this process
(Kupfer et al., 1994; Stinchcombe et al., 2001b). Micro- phocytes.
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TACTTCTGCAGCCGAATCCA-3) and 3409R (5-CCCAGCGTGTCGConcluding Remarks
TAGTCCA-3) or the G3PDH primers supplied by the manufacturer,
as a control. PCR products were subjected to electrophoresis inThe observed consequences of hMunc13-4 deficiency
1% agarose gels and detected by ethidium bromide staining.
in humans clearly demonstrate that hMunc13-4 plays a
nonredundant role in the cytotoxic pathway. HMunc13-4
Cell Cultureintervenes at a late step of the exocytic pathway, down-
Peripheral blood mononuclear cells (PBMCs) were isolated fromstream from Rab27a, and controls the fusion of lytic
whole blood from FHL3 patients, Rab27a-deficient patient (P18 in
granules with the plasma membrane. All of the mutations Me´nasche´ et al., 2000) and controls. In order to obtain PHA-induced
associated with the FHL3 phenotype in the patients T blasts, PBMCs were stimulated by incubation for 24 hr with PHA
(1/700 dilution; Difco) and IL2 (20 IU/ml; PeproTech) in 10% humanherein described abolished the functioning of this secre-
AB serum (Etablissement Franc¸ais du Sang)-supplemented Pan-tory pathway. We cannot rule out the possibility that
serin medium (Biotech GmbH). We then added IL-2 (40 IU/ml) andother mutations in hMunc13-4 result in the conservation
cultured the cells for 6–7 days (5% human AB serum, Panserin).of residual levels of activity for this Munc13 isoform,
Alternatively, lymphokine-activated killer lymphocytes (LAKs) were
potentially leading to a milder or different phenotype. produced by culturing PBMCs (10% human AB serum, Panserin)
The precise molecular mechanism of hMunc13-4 func- with large amounts of IL-2 (1500 IU/ml) for 10 days, then they were
separated on MACS columns (Miltenyi) after successive incubationtion at the immunological synapse is yet unclear. The
with phycoerythrin (PE)-conjugated anti-CD3 antibody (Becton-involvement of this protein at a stage equivalent to that
Dickinson) and anti-PE magnetic microbeads (Miltenyi) according toof Munc13-1 intervention at the neurological synapse
the manufacturer’s protocol. The CD3-positive fraction was furthersuggests a possible similar molecular interaction, to
cultured for 10 days before use.
“switch on” the fusion machinery. A complex regulation
of the vesicle secretion process is necessary in both
Functional Study of Cytotoxic T Cellstypes of synapses for the accurate delivery of storage
Cytotoxicity Assayproducts. It likely requires specialized proteins from the
Cytotoxic activity was assessed as previously described (Stepp
Munc13 family in addition to proteins generally involved et al., 1999). Briefly, the PHA blast-mediated lysis of Fas-deficient
in intracellular membrane fusion. The identification of L1210-3 target cells (chromium-51 loaded L1210-3 cells) was mea-
sured in a standard 4 hr release assay in the presence of monoclonalthese proteins will facilitate further molecular delineation
anti-CD3 antibody (OKT3, Ortoclone). The effector/target ratio wasof the mechanisms mediating tightly regulated vesicle
calculated from the number of CD8 T cells, as determined bysecretion and membrane fusion in immune cells.
flow cytometry.
Degranulation AssayExperimental Procedures
Anti-CD3 antibody (OKT3: 20g/ml) was used to coat 96-well plates,
for the stimulation of 6 105 PHA blasts/well in a 4 hr release assay.Genetic Mapping and Linkage Analysis
The cell-free supernatant was assayed for N-a-benzyloxycarbonyl-Blood samples were obtained from patients, relatives and controls.
L-lysine thiobenzyl ester (BLT) esterase (granzyme A) activity, asInformed consent was obtained from the families prior to this study.
previously described (Me´nasche´ et al., 2000) and for the presenceGenomic DNA was extracted from blood samples using standard
of 
-IFN by ELISA (R&D system).procedures. A genome-wide scan, based on 400 microsatellite
markers from ABI panel (linkage Mapping set, LMS2, Applied Bio-
system) was performed. The FASTLINK 3.0p package provided by Transfection Assay
Infobiogen (http://www.infobiogen.fr) was used for genetic linkage PHA blasts were transfected on day 7 and LAKs on day 30, using
analysis (Cottingham et al., 1993). Nucleofector Human T Cell Reagent (Amaxa) according to the manu-
facturer’s recommendations. Transfected cells were incubated in
Gene Sequencing and hMunc13-4 cDNA Cloning complete medium for four hours and IL-2 (100 IU/ml for PHA blasts
Genomic and putative mRNA sequences of hMunc13-4 were re- and 1500 UI/ml for LAKs) was then added. Twenty-four hours after
trieved from the National Center for Biotechnology Information transfection, dead cells were removed by Ficoll centrifugation and
http://www.ncbi.nlm.nih.gov (LOC201294 of the genome annotation the cytotoxicity assay was performed.
program, genomic contig NT_010641, model mRNA XM_113950).
HMun13-4 exons were sequenced in both directions, on genomic
DNA, after amplification, with the BigDye Terminator Cycle Sequenc- Immunofluorescence and Electron Microcopy
Antibodies Useding Ready Reaction Kit (Applied Biosystems). Sequencing primers
are available on request. FITC-conjugated anti-Perforin (IgG2b, Ancell); antihuman Golgi 97
(IgG1, molecular Probes); APC-conjugated anti-CD8 (IgG1), PE-con-The full-length hMunc13-4 coding sequence was assembled from
ten overlapping hMunc13-4 cDNA fragments, previously amplified jugated anti-CD3 (IgG2a) (Becton-Dickinson); PE-conjugated anti-T
cell receptor 	/ (IgG1, Immunotech); Alexafluor 488 goat antimouseby polymerase chain reaction (PCR), cloned, and sequenced. Muta-
tion-free fragments were combined by PCR, using the Expand High IgG Fab’2 secondary antibody (Molecular Probes).
Conjugate FormationFidelity PCR System (Roche Diagnostics). For functional defect
complementation, the full-length cDNA was inserted into pIRES2- L1210-3 target cells and day 20 to 30 CD3-positive LAKs were mixed
in equal quantities in the presence of anti-CD3 (5 g/ml), incubatedEGFP (Clontech) and sequenced again. For cellular localization,
hMunc13-4 was cloned in fusion with the N terminus of RFP. To for 10 min at 37C, then plated on glass coverslips coated with poly-
L-lysine (Sigma) and incubated for 20 min at 37C. Coverslips werethis aim, the full-length cDNA was subcloned into plasmid pDsRed-
N1 (Clontech), in frame with RFP, using a 3 primer in which the then placed on ice and supernatants were replaced by fixative,
depending on the application.TGA codon of hMunc13-4 was mutated into GGT followed by two
additional glycine as a linker. Fluorescence Microscopy
Conjugates were fixed by incubation in 3.7% paraformadehyde on
ice for 15 min. The cells were incubated with specific antibodies forHMunc13-4 Expression Analysis
Human multiple tissue Northern blot (Clontech) was hybridized with 45 min in a permeabilizing buffer (PBS, BSA 1 mg/ml, 0.05% saponin
[Sigma]) and washed. The cells were then incubated with DAPIa P32-labeled fragment from hMunc13-4 cDNA, under manufacturer
recommendations. PCR-ready cDNA from several tissues were pur- (0.3 M) for 15 min, washed and mounted on slides in a medium
containing Mowiol antifading agent (Calbiochem). Samples werechased from Clontech or prepared from the natural killer YT cell
line and amplified with the hMunc13-4-specific primers 3062F1 (5- observed with an Axioplan 2 microscope (Zeiss).
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Electron Microscopy de Saint Basile, G., and Fischer, A. (2001). The role of cytotoxicity
in lymphocyte homeostasis. Curr. Opin. Immunol. 13, 549–554.CTLs and target cells on coverslips were fixed in 2.5% glutaralde-
hyde in 0.1 M cacodylate buffer, [pH 7.4]. Cells were washed several Dufourcq-Lagelouse, R., Jabado, N., Le Deist, F., Stephan, J.L.,
times in cacodylate buffer and then postfixed by incubation with Souillet, G., Bruin, M., Vilmer, E., Schneider, M., Janka, G., Fischer,
2% OsO4 for 45 min, dehydrated in increasing concentrations of A., and de Saint Basile, G. (1999). Linkage of familial hemophago-
ethanol and embedded in Epon while on coverslips. Ultrathin sec- cytic lymphohistiocytosis to 10q21–22 and evidence for heterogene-
tions were prepared with a Reichert UltracutS ultramicrotome (Leica) ity. Am. J. Hum. Genet. 64, 172–179.
and viewed with a Philips TEM CM120 electron microscope (FEI
Dulubova, I., Sugita, S., Hill, S., Hosaka, M., Fernandez, I., Sudhof,
company) after counterstaining with uranyl acetate. Fifty conjugates
T.C., and Rizo, J. (1999). A conformational switch in syntaxin during
were analyzed for each situation.
exocytosis: role of munc18. EMBO J. 18, 4372–4382.
Fernandez, I., Arac, D., Ubach, J., Gerber, S.H., Shin, O., Gao, Y.,Acknowledgments
Anderson, R.G., Sudhof, T.C., and Rizo, J. (2001). Three-dimensional
structure of the synaptotagmin 1 C2B-domain: synaptotagmin 1 asWe thank Dr. R. Dufourcq-Lagelouse for his participation in the early
a phospholipid binding machine. Neuron 32, 1057–1069.phase of this work; Olivier Gribouval for his technical advice; and
Fortier, A.H., Nacy, C.A., and Sitkovsky, M.V. (1989). Similar molecu-Prof. Lutz, Dr. S. Dupuis, and Dr. M. Duval who took care of the
lar requirements for antigen receptor-triggered secretion of inter-patients. We thank G. Me´nasche´ for helpful discussions. This work
feron and granule enzymes by cytolytic T lymphocytes. Cell. Immu-was supported by grants from the Institut National de la Sante´ et
nol. 124, 64–76.de la Recherche Me´dicale (INSERM), l’Association de Recherche
contre le cancer (ARC), the association Vaincre les Maladies Lysoso- Griffiths, G.M., and Isaaz, S. (1993). Granzymes A and B are targeted
males (VML), and the Louis Jeantet Fundation. J.F. was supported to the lytic granules of lymphocytes by the mannose-6-phosphate
by doctoral fellowships from the Ministe`re de l’Education Nationale, receptor. J. Cell Biol. 120, 885–896.
de la Recherche et de la Technologie, l’ARC, and the Fondation Haddad, E.K., Wu, X., Hammer, J.A., and Henkart, P.A. (2001). Defec-
pour la Recherche Me´dicale. tive granule exocytosis in rab27a-deficient lymphocytes from ashen
mice. J. Cell Biol. 152, 835–842.
Received: July 31, 2003
Hu, C., Ahmed, M., Melia, T.J., Sollner, T.H., Mayer, T., and Rothman,
Revised: October 8, 2003
J.E. (2003). Fusion of cells by flipped SNAREs. Science 300, 1745–
Accepted: October 10, 2003
1749.
Published: November 13, 2003
Jahn, R., and Sudhof, T.C. (1999). Membrane fusion and exocytosis.
Annu. Rev. Biochem. 68, 863–911.References
Jahn, R., Lang, T., and Sudhof, T.C. (2003). Membrane fusion. Cell
112, 519–533.Ashery, U., Varoqueaux, F., Voets, T., Betz, A., Thakur, P., Koch, H.,
Neher, E., Brose, N., and Rettig, J. (2000). Munc13–1 acts as a Jones, D.T. (1999). Protein secondary structure prediction based on
priming factor for large dense-core vesicles in bovine chromaffin position-specific scoring matrices. J. Mol. Biol. 292, 195–202.
cells. EMBO J. 19, 3586–3596. Koch, H., Hofmann, K., and Brose, N. (2000). Definition of Munc13-
Augustin, I., Betz, A., Herrmann, C., Jo, T., and Brose, N. (1999a). homology-domains and characterization of a novel ubiquitously ex-
Differential expression of two novel Munc13 proteins in rat brain. pressed Munc13 isoform. Biochem. J. 349, 247–253.
Biochem. J. 337, 363–371. Kupfer, A., and Singer, S.J. (1989). Cell biology of cytotoxic and
Augustin, I., Rosenmund, C., Sudhof, T.C., and Brose, N. (1999b). helper T cell functions: immunofluorescence microscopic studies
Munc13–1 is essential for fusion competence of glutamatergic syn- of single cells and cell couples. Annu. Rev. Immunol. 7, 309–337.
aptic vesicles. Nature 400, 457–461. Kupfer, H., Monks, C.R., and Kupfer, A. (1994). Small splenic B cells
Baetz, K., Isaaz, S., and Griffiths, G.M. (1995). Loss of cytotoxic that bind to antigen-specific T helper (Th) cells and face the site of
T lymphocyte function in Chediak-Higashi syndrome arise from a cytokine production in the Th cells selectively proliferate: immuno-
secretory defect that prevents lytic granule exocytosis. J. Immunol. fluorescence microscopic studies of Th-B antigen-presenting cell
154, 6122–6131. interactions. J. Exp. Med. 179, 1507–1515.
Betz, A., Okamoto, M., Benseler, F., and Brose, N. (1997). Direct Lin, R.C., and Scheller, R.H. (2000). Mechanisms of synaptic vesicle
interaction of the rat unc-13 homologue Munc13–1 with the N termi- exocytosis. Annu. Rev. Cell Dev. Biol. 16, 19–49.
nus of syntaxin. J. Biol. Chem. 272, 2520–2526. Me´nasche´, G., Pastural, E., Feldmann, J., Certain, S., Ersoy, F.,
Betz, A., Ashery, U., Rickmann, M., Augustin, I., Neher, E., Sudhof, Dupuis, S., Wulffraat, N., Bianci, D., Fischer, A., Le Deist, F., and
T.C., Rettig, J., and Brose, N. (1998). Munc13–1 is a presynaptic de Saint Basile, G. (2000). Mutations in RAB27A cause Griscelli
phorbol ester receptor that enhances neurotransmitter release. syndrome associated with hemophagocytic syndrome. Nat. Genet.
Neuron 21, 123–136. 25, 173–176.
Betz, A., Thakur, P., Junge, H.J., Ashery, U., Rhee, J.S., Scheuss, Nagle, D.L., Karim, A.M., Woolf, E.A., Holmgren, L., Bork, P., Misumi,
V., Rosenmund, C., Rettig, J., and Brose, N. (2001). Functional inter- D.J., McGrail, S.H., Dussault, B.J., Perou, C.M., Boissy, R.E., et al.
action of the active zone proteins Munc13–1 and RIM1 in synaptic (1996). Identification and mutation analysis of the complete gene
vesicle priming. Neuron 30, 183–196. for Chediak-Higashi syndrome. Nat. Genet. 14, 307–311.
Brose, N., Hofmann, K., Hata, Y., and Sudhof, T.C. (1995). Mamma- Nalefski, E.A., and Falke, J.J. (1996). The C2 domain calcium-binding
lian homologues of Caenorhabditis elegans unc-13 gene define motif: structural and functional diversity. Protein Sci. 5, 2375–2390.
novel family of C2-domain proteins. J. Biol. Chem. 270, 25273– Ohadi, M., Lalloz, M.R., Sham, P., Zhao, J., Dearlove, A.M., Shiach,
25280. C., Kinsey, S., Rhodes, M., and Layton, D.M. (1999). Localization of
Brose, N., Rosenmund, C., and Rettig, J. (2000). Regulation of trans- a gene for familial hemophagocytic lymphohistiocytosis at chromo-
mitter release by Unc-13 and its homologues. Curr. Opin. Neurobiol. some 9q21.3–22 by homozygosity mapping. Am. J. Hum. Genet.
10, 303–311. 64, 165–171.
Callebaut, I., Labesse, G., Durand, P., Poupon, A., Canard, L., Chom- Orita, S., Naito, A., Sakaguchi, G., Maeda, M., Igarashi, H., Sasaki,
ilier, J., Henrissat, B., and Mornon, J.P. (1997). Deciphering protein T., and Takai, Y. (1997). Physical and functional interactions of Doc2
sequence information through hydrophobic cluster analysis (HCA): and Munc13 in Ca2-dependent exocytotic machinery. J. Biol.
current status and perspectives. Cell. Mol. Life Sci. 53, 621–645. Chem. 272, 16081–16084.
Perisic, O., Fong, S., Lynch, D.E., Bycroft, M., and Williams, R.L.Cottingham, R.W., Jr., Idury, R.M., and Schaffer, A.A. (1993). Faster
sequential genetic linkage computations. Am. J. Hum. Genet. 53, (1998). Crystal structure of a calcium-phospholipid binding domain
from cytosolic phospholipase A2. J. Biol. Chem. 273, 1596–1604.252–263.
Munc13-4 and Lytic Granules Fusion Defect in FHL3
473
Peters, P.J., Geuze, H.J., Van der Donk, H.A., Slot, J.W., Griffith, J.M.,
Stam, N.J., Clevers, H.C., and Borst, J. (1989). Molecules relevant for
T cell-target cell interaction are present in cytolytic granules of hu-
man T lymphocytes. Eur. J. Immunol. 19, 1469–1475.
Richmond, J.E., Weimer, R.M., and Jorgensen, E.M. (2001). An open
form of syntaxin bypasses the requirement for UNC-13 in vesicle
priming. Nature 412, 338–341.
Rizo, J., and Sudhof, T.C. (1998). C2-domains, structure and function
of a universal Ca2-binding domain. J. Biol. Chem. 273, 15879–
15882.
Rizo, J., and Sudhof, T.C. (2002). Snares and Munc18 in synaptic
vesicle fusion. Nat. Rev. Neurosci. 3, 641–653.
Rothstein, T.L., Mage, M., Jones, G., and McHugh, L.L. (1978). Cyto-
toxic T lymphocyte sequential killing of immobilized allogeneic tu-
mor target cells measured by time-lapse microcinematography. J.
Immunol. 121, 1652–1656.
Russell, J.H., and Ley, T.J. (2002). Lymphocyte-mediated cytotoxic-
ity. Annu. Rev. Immunol. 20, 323–370.
Sali, A., Potterton, L., Yuan, F., van Vlijmen, H., and Karplus, M.
(1995). Evaluation of comparative protein modeling by MODELLER.
Proteins 23, 318–326.
Sassa, T., Harada, S., Ogawa, H., Rand, J.B., Maruyama, I.N., and
Hosono, R. (1999). Regulation of the UNC-18-Caenorhabditis ele-
gans syntaxin complex by UNC-13. J. Neurosci. 19, 4772–4777.
Shiratsuchi, T., Oda, K., Nishimori, H., Suzuki, M., Takahashi, E.,
Tokino, T., and Nakamura, Y. (1998). Cloning and characterization
of BAP3 (BAI-associated protein 3), a C2 domain-containing protein
that interacts with BAI1. Biochem. Biophys. Res. Commun. 251,
158–165.
Shresta, S., Pham, C.T., Thomas, D.A., Graubert, T.A., and Ley, T.J.
(1998). How do cytotoxic lymphocytes kill their targets? Curr. Opin.
Immunol. 10, 581–587.
Stepp, S., Dufourcq-Lagelouse, R., Le Deist, F., Bhawan, S., Certain,
S., Mathew, P., Henter, J., Bennett, M., Fischer, A., de Saint Basile,
G., and Kumar, V. (1999). Perforin gene defects in familial hemopha-
gocytic lymphohistiocytosis. Science 286, 1957–1959.
Stinchcombe, J.C., Barral, D.C., Mules, E.H., Booth, S., Hume, A.N.,
Machesky, L.M., Seabra, M.C., and Griffiths, G.M. (2001a). Rab27a
is required for regulated secretion in cytotoxic t lymphocytes. J.
Cell Biol. 152, 825–834.
Stinchcombe, J.C., Bossi, G., Booth, S., and Griffiths, G.M. (2001b).
The immunological synapse of CTL contains a secretory domain
and membrane bridges. Immunity 15, 751–761.
Sutton, R.B., Ernst, J.A., and Brunger, A.T. (1999). Crystal structure
of the cytosolic C2A–C2B domains of synaptotagmin III. Implications
for Ca(2)-independent snare complex interaction. J. Cell Biol.
147, 589–598.
Ubach, J., Garcia, J., Nittler, M.P., Sudhof, T.C., and Rizo, J. (1999).
Structure of the Janus-faced C2B domain of rabphilin. Nat. Cell Biol.
1, 106–112.
Vyas, Y.M., Maniar, H., and Dupont, B. (2002). Visualization of signal-
ing pathways and cortical cytoskeleton in cytolytic and noncytolytic
natural killer cell immune synapses. Immunol. Rev. 189, 161–178.
Weber, T., Zemelman, B.V., McNew, J.A., Westermann, B., Gmachl,
M., Parlati, F., Sollner, T.H., and Rothman, J.E. (1998). SNAREpins:
minimal machinery for membrane fusion. Cell 92, 759–772.
Zerial, M., and McBride, H. (2001). Rab proteins as membrane orga-
nizers. Nat. Rev. Mol. Cell. Biol. 2, 107–117.
Accession Numbers
Human Munc13-4 cDNA sequence was deposited into EMBL under
accession number AJ578444.
